Status:

COMPLETED

Adapting an Evidenced-based Weight Management Intervention and Testing Strategies to Increase Implementation in Community Mental Health Programs

Lead Sponsor:

Johns Hopkins University

Conditions:

Overweight and Obesity

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This is a pilot randomized clinical trial testing an implementation intervention to support delivery of a behavioral weight loss program at community mental health programs.

Detailed Description

This is a pilot randomized clinical trial testing an implementation intervention to support delivery of a behavioral weight loss program at community mental health programs. Investigators will conduct...

Eligibility Criteria

Inclusion

  • Coaches -
  • Adult staff or peer at community mental health program
  • Willing and able to participate in training and delivery of intervention
  • Consumers-
  • Age 18 and older
  • Enrolled in a psychiatric rehabilitation program
  • BMI ≥ 25 kg/m2
  • Willing to make changes in diet and exercise to lose weight
  • Willing to attend the ACHIEVE group sessions virtually or in-person at least once per week
  • Ability to use a computer or tablet
  • Competent and willing to give informed oral consent
  • Completion of baseline data collection

Exclusion

  • Any underlying medical conditions that could seriously reduce life expectancy, ability to participate in the study, or for which dietary change/physical activity/weight loss may be contraindicated e.g., Lung disease requiring supplemental oxygen Liver failure History of anorexia nervosa or bulimia Stage V kidney disease on dialysis Cardiovascular event in the last 6 months including unstable angina, myocardial infarction, congestive heart failure, transient ischemic attack, or stroke
  • Insulin dependent diabetes
  • Inability to walk unassisted (e.g., uses a cane, walker, etc)
  • Pregnant, breastfeeding, or planning a pregnancy during study period
  • Prior or planned bariatric surgery
  • Use of a prescription anti-obesity medication or over-the-counter orlistat within the past 3 months
  • Self-reported weight loss of \>20 lbs in the last 3 months
  • Active substance use disorder, alcohol use disorder, or problem drinking (more than 14 drinks per week for women, more than 21 drinks per week for men)
  • Planning to leave mental health program or move out of geographic area within 12 months
  • Weight greater than 440 pounds (so as not to exceed capacity of study scale)
  • Investigator judgment (e.g., for concerns over safety, adherence or follow-up)

Key Trial Info

Start Date :

March 16 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 30 2023

Estimated Enrollment :

92 Patients enrolled

Trial Details

Trial ID

NCT03454997

Start Date

March 16 2021

End Date

March 30 2023

Last Update

August 20 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Joseph Gennusa

Baltimore, Maryland, United States, 21224